Literature DB >> 32253630

Understanding Naloxone Uptake from an Emergency Department Distribution Program Using a Low-Energy Bluetooth Real-time Location System.

Jeffrey T Lai1, Brittany P Chapman2, Stephanie P Carreiro2, Kavita M Babu2, Edward W Boyer3, Peter R Chai3.   

Abstract

INTRODUCTION: Emergency department (ED)-based naloxone distribution programs are a widespread harm reduction strategy. However, data describing the community penetrance of naloxone distributed from these programs are lacking. This study gauges acceptance of naloxone use and monitoring technology among people who use drugs (PWUD), and explores the use of real-time location systems (RTLS) in monitoring naloxone movements.
METHODS: A prospective observational study was conducted on a convenience sample of individuals (N = 30) presenting to a tertiary-care academic medical center ED for an opioid-related complaint. A naloxone kit equipped with a low-energy Bluetooth (BLE) tracking system was employed to detect movement of naloxone off the hospital campus as a proxy for community penetrance, followed by a qualitative interview to gauge participant acceptance of naloxone use and monitoring technology.
RESULTS: Detection of BLE signals verified transit of 24 distributed naloxone kits off our hospital campus. Three participants whose BLE signals were not captured reported taking their kits with them following discharge, suggesting technological errors occurred; another three participants were lost to follow-up. Qualitative interviews demonstrated that participants accepted ED-based naloxone distribution programs and passive tracking technologies, but revealed concerns regarding hypothetical continuous monitoring systems and problematic interactions with first responders and law enforcement personnel.
CONCLUSIONS: Based on acquired BLE signals, 80% of dispensed naloxone kits left the hospital campus. Use of RTLS to passively geolocate naloxone rescue kits is feasible, but detection can be adversely affected by technological errors. PWUD are amenable to transient monitoring technologies but identified barriers to implementation.

Entities:  

Keywords:  Digital health; Harm reduction; Naloxone; Opioids; Technology

Mesh:

Substances:

Year:  2020        PMID: 32253630      PMCID: PMC7554286          DOI: 10.1007/s13181-020-00774-8

Source DB:  PubMed          Journal:  J Med Toxicol        ISSN: 1556-9039


  14 in total

1.  Cost-effectiveness of distributing naloxone to heroin users for lay overdose reversal.

Authors:  Phillip O Coffin; Sean D Sullivan
Journal:  Ann Intern Med       Date:  2013-01-01       Impact factor: 25.391

2.  Cost-Effectiveness of Take-Home Naloxone for the Prevention of Overdose Fatalities among Heroin Users in the United Kingdom.

Authors:  Sue Langham; Antony Wright; James Kenworthy; Richard Grieve; William C N Dunlop
Journal:  Value Health       Date:  2018-02-04       Impact factor: 5.725

3.  Barriers to implementation of opioid overdose prevention programs in Ohio.

Authors:  Erin L Winstanley; Angela Clark; Judith Feinberg; Christine M Wilder
Journal:  Subst Abus       Date:  2016       Impact factor: 3.716

4.  Potency, duration of action and pA2 in man of intravenous naloxone measured by reversal of morphine-depressed respiration.

Authors:  R D Kaufman; M L Gabathuler; J W Bellville
Journal:  J Pharmacol Exp Ther       Date:  1981-10       Impact factor: 4.030

5.  Naloxone Use Among Emergency Department Patients with Opioid Overdose.

Authors:  Catherine A Marco; William Trautman; Alexander Cook; Dennis Mann; Jordan Rasp; Oswald Perkins; Michael Ballester
Journal:  J Emerg Med       Date:  2018-07       Impact factor: 1.484

6.  Attitudes about prescribing take-home naloxone to injection drug users for the management of heroin overdose: a survey of street-recruited injectors in the San Francisco Bay Area.

Authors:  Karen H Seal; Moher Downing; Alex H Kral; Shannon Singleton-Banks; Jon-Paul Hammond; Jennifer Lorvick; Dan Ciccarone; Brian R Edlin
Journal:  J Urban Health       Date:  2003-06       Impact factor: 3.671

7.  Non-fatal overdoses and related risk factors among people who inject drugs in St. Petersburg, Russia and Kohtla-Järve, Estonia.

Authors:  Anneli Uusküla; Mait Raag; Sigrid Vorobjov; Kristi Rüütel; Alexandra Lyubimova; Olga S Levina; Robert Heimer
Journal:  BMC Public Health       Date:  2015-12-18       Impact factor: 3.295

8.  Effectiveness of bystander naloxone administration and overdose education programs: a meta-analysis.

Authors:  Rebecca E Giglio; Guohua Li; Charles J DiMaggio
Journal:  Inj Epidemiol       Date:  2015-05-22

9.  Knowledge and possession of take-home naloxone kits among street-involved youth in a Canadian setting: a cohort study.

Authors:  Julia Goldman-Hasbun; Kora DeBeck; Jane A Buxton; Ekaterina Nosova; Evan Wood; Thomas Kerr
Journal:  Harm Reduct J       Date:  2017-12-22

10.  Drug and Opioid-Involved Overdose Deaths - United States, 2013-2017.

Authors:  Lawrence Scholl; Puja Seth; Mbabazi Kariisa; Nana Wilson; Grant Baldwin
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2018-01-04       Impact factor: 17.586

View more
  2 in total

1.  Prescribing Naloxone to High-Risk Patients in the Emergency Department: Is it Enough?

Authors:  Scott G Weiner; Jason A Hoppe
Journal:  Jt Comm J Qual Patient Saf       Date:  2021-04-04

2.  Improving Care Delivery: Location Timestamps to Enhance Process Measurement of a Clinical Workflow.

Authors:  Lindsey Barrick; Danny T Y Wu; Theresa Frey; Derek Shu; Ruthvik Abbu; Stephen C Porter; Kevin M Overmann
Journal:  Pediatr Qual Saf       Date:  2021-09-24
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.